J70.3 – Chronic drug-induced interstitial lung disorders

ICD-10-CM 2027 diagnosis code · Lung diseases due to external agents

Billable code

ICD-10-CM code J70.3

Code: J70.3 (claims format: J703)
Description: Chronic drug-induced interstitial lung disorders
Billable: Yes – valid for HIPAA-covered transactions
Valid for: Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter: 10. Diseases of the respiratory system (J00-J99)
Block: J60-J70 Lung diseases due to external agents
Parent codes: J70

Notes for J70.3

Excludes1 (not coded here):

interstitial pneumonia NOS (J84.9)
lymphoid interstitial pneumonia (J84.2)

Use additional code:

code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

Block J60-J70

Excludes2 (not included here):

asthma (J45.-)
malignant neoplasm of bronchus and lung (C34.-)

Index terms for J70.3

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in J70

Frequently asked questions

What is ICD-10 code J70.3?

J70.3 is the ICD-10-CM code for chronic drug-induced interstitial lung disorders, in the block J60-J70 (Lung diseases due to external agents).

Is J70.3 a billable code?

Yes. J70.3 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does J70.3 belong to?

It belongs to category J70 – Respiratory conditions due to other external agents.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.